These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 18422783

  • 1. Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.
    Park HJ, Neelapu SS.
    Br J Haematol; 2008 Jun; 142(2):179-91. PubMed ID: 18422783
    [Abstract] [Full Text] [Related]

  • 2. Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
    Hurvitz SA, Timmerman JM.
    Curr Opin Oncol; 2005 Sep; 17(5):432-40. PubMed ID: 16093791
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R.
    Cancer Res; 2002 Oct 15; 62(20):5845-52. PubMed ID: 12384547
    [Abstract] [Full Text] [Related]

  • 4. Vaccination strategies in follicular lymphoma.
    Kannan S, Neelapu SS.
    Curr Hematol Malig Rep; 2009 Oct 15; 4(4):189-95. PubMed ID: 20425407
    [Abstract] [Full Text] [Related]

  • 5. Translational development of vaccination strategies in follicular NHL.
    Sakamaki I, Qin H, Kwak LW.
    Best Pract Res Clin Haematol; 2011 Jun 15; 24(2):295-304. PubMed ID: 21658625
    [Abstract] [Full Text] [Related]

  • 6. Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin's lymphomas: a focus on FavId.
    Hurvitz SA, Timmerman JM.
    Expert Opin Biol Ther; 2005 Jun 15; 5(6):841-52. PubMed ID: 15952914
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.
    Timmerman JM.
    Adv Pharmacol; 2004 Jun 15; 51():271-93. PubMed ID: 15464914
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA, Neelapu SS, Kwak LW, Biragyn A.
    Haematologica; 2002 Sep 15; 87(9):989-1001. PubMed ID: 12217812
    [Abstract] [Full Text] [Related]

  • 13. Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma.
    Ruffini PA, Di Nicola M, Carlo-Stella C, Siena S, Gianni AM.
    Curr Gene Ther; 2005 Oct 15; 5(5):511-21. PubMed ID: 16250891
    [Abstract] [Full Text] [Related]

  • 14. Vaccination strategies for lymphomas.
    Dar MM, Kwak LW.
    Curr Oncol Rep; 2003 Sep 15; 5(5):380-6. PubMed ID: 12895388
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. New strategies for vaccination and imunomodulation in NHL.
    Stevenson FK, Zhu D, Rice J.
    Ann Hematol; 2001 Sep 15; 80 Suppl 3():B132-4. PubMed ID: 11757697
    [Abstract] [Full Text] [Related]

  • 17. Active immunotherapy: current state of the art in vaccine approaches for NHL.
    Palomba ML.
    Curr Oncol Rep; 2012 Oct 15; 14(5):433-40. PubMed ID: 22843515
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic idiotype vaccines in B lymphoproliferative diseases.
    Coscia M, Kwak LW.
    Expert Opin Biol Ther; 2004 Jun 15; 4(6):959-63. PubMed ID: 15174977
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic vaccine for lymphoma.
    Lee ST, Neelapu SS, Kwak LW.
    Yonsei Med J; 2007 Feb 28; 48(1):1-10. PubMed ID: 17326239
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.